| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |